There is currently no FDA approved treatment for post Covid syndrome/Covid long-hauler. However, there are several clinical trials being conducted with the approval of the FDA under IND (Investigational New Drug) clinical protocols.

The information and the experience patients share with us is paramount to uncovering possible clinical pathways of disease and further research. Please inquire if you are interested in further information regarding qualifications for said studies and for any published data regarding post COVID syndrome/Covid long-hauler.

Please see the latest publication conducted by Dr. Angel Lazo, Jr., here.